Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02203656Phase 1Completed
Phase 1, randomised, single-blind trial of testosterone in Sarcopenia (5 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Short Physical Performance Battery at 4 weeks. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02203656.